China: Sequoia-backed biopharma startup JHL Biotech raises $106m

China: Sequoia-backed biopharma startup JHL Biotech raises $106m

Photo by Martin Lopez from Pexels

JHL Biotech, a biopharmaceutical company backed by Sequoia Capital, has raised $106 million by selling convertible bonds in a round led by Hong Kong-based private equity firm VMS Investment Group, and joined by existing shareholders.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter